These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13. Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A; Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566 [TBL] [Abstract][Full Text] [Related]
46. Multiple marker screening for Down syndrome in the first trimester of pregnancy. Wallace EM Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):368-70. PubMed ID: 9325534 [No Abstract] [Full Text] [Related]
50. Detection of trisomy 21 in a fetus during the investigation for Tay-Sachs disease. Alpman A; Bora E; Karaca E; Cankaya T; Onay H; Cogulu O; Gunduz C; Kleijer WJ; Ozkinay F Genet Couns; 2004; 15(1):99-100. PubMed ID: 15083708 [No Abstract] [Full Text] [Related]
51. Early decision. Will new advances in prenatal testing shrink the ranks of babies with Down syndrome? Rochman B Time; 2012 Feb; 179(8):36-40. PubMed ID: 22462306 [No Abstract] [Full Text] [Related]
52. A parent's guide to the genetics of Down syndrome. Hartway S Adv Neonatal Care; 2009 Feb; 9(1):27-30. PubMed ID: 19212162 [TBL] [Abstract][Full Text] [Related]
53. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters. Zhang J; Lambert-Messerlian G; Palomaki GE; Canick JA Prenat Diagn; 2011 Jun; 31(6):583-8. PubMed ID: 21480302 [TBL] [Abstract][Full Text] [Related]
54. Cross-trimester marker ratios in prenatal screening for Down syndrome. Wald NJ; Bestwick JP; Morris JK Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232 [TBL] [Abstract][Full Text] [Related]
55. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program. Krantz DA; Hallahan TW; Macri VJ; Macri JN Prenat Diagn; 2005 Aug; 25(8):635-40. PubMed ID: 16049986 [TBL] [Abstract][Full Text] [Related]
56. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Benn PA; Ying J; Beazoglou T; Egan JF Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240 [TBL] [Abstract][Full Text] [Related]
57. Screening for trisomy 21 in Flanders: a 10 years review of 40.490 pregnancies screened by maternal serum. Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; Martens GE; de Jonge ET; Ombelet WU; Nijhuis JG Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):185-9. PubMed ID: 15262353 [TBL] [Abstract][Full Text] [Related]
58. Prenatal diagnosis now and in the future, in a genetic perspective. Wahlström J Acta Obstet Gynecol Scand; 2000 Nov; 79(11):925-7. PubMed ID: 11081672 [No Abstract] [Full Text] [Related]
59. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers. Skotko B Obstet Gynecol; 2006 May; 107(5):1170. PubMed ID: 16648429 [No Abstract] [Full Text] [Related]
60. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing. Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]